About this trial
The aims of this study are to
1. Identify the early and midterm outcomes in terms of mortality and reoperation of the arterial switch operation (ASO). 2. Identifying the influence of coronary artery anomalies on the in-hospital and post-discharge prognosis after ASO. 3. Evaluate the predictors for neoaortic valve regurgitation after ASO. 4. Explore the risk factors for neopulmonary artery stenosis after ASO.
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients with various forms of TGA undergoing Réparation à l'Etage Ventriculaire procedure
Patients with various forms of TGA undergoing Rastelli procedure
Patients with various forms of TGA undergoing Nikaidoh procedure
Patients with various forms of TGA undergoing Fontan operation
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
Sponsors and collaborators
Xie Mingxing
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Sponsor institution
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborator
Shanghai Zhongshan Hospital
Collaborator
Henan Provincial People's Hospital
Collaborator
Wuhan Asia Heart Hospital
Collaborator
Guangdong Provincial People's Hospital
Collaborator